ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
bullishSK Inc
04 Oct 2021 20:09

SK Inc - SoTP Valuation Analysis and 3 Key Catalysts (SK E&S, SK Pharmteco, & SK Siltron)

In this insight, we provide an updated NAV valuation analysis of SK Inc. Our updated base case valuation of SK Inc is 381,838 won per share,...

Logo
294 Views
Share
04 Sep 2021 06:03

Asia Shorts: Alibaba, CMB, Tencent, Anta, Shiseido, Odakyu, Keio, NC Soft, LGD, SK Tel, Evergreen

The Insight looks at movements in short interest across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
212 Views
Share
25 Aug 2021 08:42

AmbioPharm (昂博制药) Pre-IPO: Peptide CDMO Leader Turning Licensor

AmbioPharm is a global leader in the peptide CDMO business and will further monetizing its expertise by collaborating with partners to develop...

Logo
788 Views
Share
14 Aug 2021 07:02

Asia Shorts: HKEX, Mengniu, Kuaishou, AIA, Sharp, Yaskawa, Kumho, HMC, Celltrion, TSMC, Yang Ming

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
275 Views
Share
bullishSamsung C&T
10 Aug 2021 01:07

Samsung's Lee Jae-Yong Gets Out of Jail (Again) & NAV Analysis of Samsung C&T

It was announced today that Samsung's Lee Jae-Yong will get out of jail as the Korean government will release him on parole this week after he...

Logo
288 Views
Share
x